Neuro-Oncology

No one investigator is going to find solutions for pediatric brain and spinal cord tumors alone. That’s why our team is deeply rooted in global initiatives around the world to provide solutions and advance discovery. If there is a collaborative effort to find new discoveries for pediatric brain and spinal cord tumors, our team is a part of it. 

Acute Myeloid Leukemia

Researchers Studying Donor NK Cell Infusions in patients with High-Risk AML Undergoing a HaploHCT

Researchers Studying Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed, Refractory AML

Adamantinomatous Craniopharyngioma (ACP)

Researchers Studying IV Medicine to Treat Pediatric Adamantinomatous Craniopharyngioma (ACP)

 

Researchers Studying Oral Drug to Treat Pediatric Adamantinomatous Craniopharyngioma (ACP)

 

Central Nervous System (CNS) Tumors

Researchers Studying Oral Medicine to Treat Medulloblastoma, High-Grade Glioma, DIPG Brain Tumors and Other Brain Tumor Types

Researchers Studying IV Medicine to Treat Youth and Young Adults With Recurrent or Progressive High-Grade Central Nervous System Tumors and Meningiomas

Researchers Studying Oral Medicine for Solid Tumors Dependent on KIT or PDGFRA Signaling

Researchers Studying Oral Medication to See if it Protects the Brain During Radiation Therapy Treatment for Primary Central Nervous System Tumors

Diffuse Intrinsic Pontine Glioma (DIPG)

Researchers Studying Oral Medicine During and After Radiation to Treat Newly Diagnosed DIPG and HGG

Researchers Studying Maximum Tolerated Dose of IV Infusion and Radiation Therapy in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (KONQUER)

Researchers Studying Oral Medicine During and After Radiation to Treat Newly Diagnosed DIPG and HGG

Gliomas

Researchers Studying Effectiveness of Oral Medicine Combinations to Treat Children with Recurrent or Progressive Pediatric Low-Grade Glioma

Researchers Studying Oral Medicine to Treat Newly Diagnosed High-Grade Glioma With NTRK Fusion

Researchers Compare Oral Drug Treatment With IV Drug Treatment in Patients With Neurofibromatosis and Low-Grade Glioma

Researchers Studying Oral Medication Combination After Radiation Therapy to Treat Patients With Newly Diagnosed High-Grade Glioma

Medulloblastoma

Researchers Studying Reduced Craniospinal Radiation Therapy and Chemotherapy for Patients With Newly Diagnosed WNT-Driven Medulloblastoma

Neuroblastoma

Researchers Studying Universal Donor NK Cells in Combination with IV Drug Therapy in Patients With Relapsed or Refractory Neuroblastoma

Sarcomas

Researchers Studying Donor NK Cell Infusions Combined With IV Medications in Patients With Relapsed or Refractory Pediatric Sarcomas